BRIEF published on 03/20/2026 at 15:49, 15 days 7 hours ago Guerbet: Publication of the 2025 Universal Registration Document Financial Report Guerbet Medical Imaging Financial Markets Registration Document
BRIEF published on 03/20/2026 at 15:49, 15 days 7 hours ago Guerbet : Publication du Document d'enregistrement universel 2025 Rapport Financier Guerbet Imagerie Médicale Marchés Financiers Document D'enregistrement
PRESS RELEASE published on 03/20/2026 at 15:44, 15 days 7 hours ago GUERBET : Mise à disposition du Document d’enregistrement universel 2025 Guerbet dépose son Document d’enregistrement universel 2025 à l'AMF. Consultation gratuite en ligne. Prochain RDV : Publication du chiffre d’affaires du 1er trimestre 2026 le 23 avril 2026 Chiffre D’affaires AMF Guerbet Publication Document D’Enregistrement Universel 2025
BRIEF published on 02/20/2026 at 17:50, 1 month 12 days ago Guerbet: Capital update as of January 31, 2026 Voting Rights Capital Actions Guerbet 2026
BRIEF published on 02/20/2026 at 17:50, 1 month 12 days ago Guerbet : Mise à jour sur le capital au 31 janvier 2026 Capital Droits De Vote Actions Guerbet 2026
PRESS RELEASE published on 02/20/2026 at 17:45, 1 month 12 days ago GUERBET : Nombre d'actions et de droits de vote composant le capital de la société au 31 janvier 2026 Déclaration du nombre de droits de vote et d'actions composant le capital d'une société, conformément à la réglementation en vigueur Droits De Vote Code De Commerce Actions AMF Société
BRIEF published on 01/27/2026 at 18:10, 2 months 8 days ago Approbation européenne pour l'utilisation d'Elucirem™ de Guerbet chez l'enfant dès la naissance Guerbet Commission Européenne Elucirem™ Imagerie Pédiatrique Contraste À Base De Gadolinium
BRIEF published on 01/27/2026 at 18:10, 2 months 8 days ago European Approval for Guerbet's Elucirem™ Use in Children from Birth European Commission Guerbet Elucirem™ Pediatric Imaging Gadolinium-Based Contrast
PRESS RELEASE published on 01/27/2026 at 18:05, 2 months 8 days ago New indication in children from birth for Guerbet's half-dose GBCA, Elucirem™ (Gadopiclenol) approved by European Commission Guerbet's Elucirem (Gadopiclenol) receives European Commission approval for new indication in children from birth, with half-dose GBCA for MRI imaging European Commission Guerbet MRI Imaging Elucirem Gadopiclenol
BRIEF published on 12/19/2025 at 08:50, 3 months 16 days ago Guerbet nomme François Convenant à un poste de direction clé Comité Exécutif Guerbet Innovation Dans Le Secteur De La Santé François Convenant Radiologie Interventionnelle
Published on 04/02/2026 at 22:00, 2 days 1 hour ago Star Copper Announces Closing of Charity Flow-Through Unit Private Placement
Published on 04/02/2026 at 18:32, 2 days 5 hours ago Datavault AI CEO Nathaniel Bradley to Present DataValue(R), DataScore(R), and Information Data Exchange(R) Technologies at XRP Tokyo 2026
Published on 04/02/2026 at 15:00, 2 days 8 hours ago Jaguar Health Family Company Napo Pharmaceuticals Co-Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress
Published on 04/02/2026 at 14:40, 2 days 8 hours ago Northfield Capital Completes Acquisition Of Additional Interest In Juno Corp. And Announces Issuance Of Class B Multiple Voting Shares
Published on 04/02/2026 at 14:30, 2 days 9 hours ago Worksport Announces COR(TM) Portable Energy System Is Now Fully Certified, Including Key UL and CSA Approvals, for North American Retail and Commercial Distribution
Published on 04/04/2026 at 10:07, 13 hours 32 minutes ago Heidelberg Pharma to Present Data from its ADC Technology Platform at AACR Annual Meeting 2026
Published on 04/04/2026 at 02:05, 21 hours 34 minutes ago Blokees made its debut at 2026 Thailand Toy Expo, exhibiting multiple products
Published on 04/03/2026 at 18:00, 1 day 5 hours ago IEVA GROUP: IMPLEMENTATION OF A LIQUIDITY AGREEMENT WITH CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 18:00, 1 day 5 hours ago IEVA GROUP: MISE EN OEUVRE D’UN CONTRAT DE LIQUIDITE AVEC LE CREDIT INDUSTRIEL ET COMMERCIAL
Published on 04/03/2026 at 17:45, 1 day 5 hours ago Atbash Launches on Chromia to Enable Verifiable, User-Controlled AI Systems
Published on 04/03/2026 at 18:46, 1 day 4 hours ago Disclosure of Share Capital and Voting Rights as of March 31, 2026
Published on 04/03/2026 at 18:46, 1 day 4 hours ago Déclaration du nombre d’actions et droits de vote au 31 mars 2026
Published on 04/03/2026 at 18:01, 1 day 5 hours ago ALTAREIT : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 1 day 5 hours ago ALTAREA : INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 04/03/2026 at 18:00, 1 day 5 hours ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 mars 2026
